Caravel Oculus
ABOUT US
Caravel Oculus Inc. was founded by a team of professionals with extensive experience in pharmaceutical marketing, focusing on the development of ophthalmic drugs. With a pragmatic and efficient approach, we aim to address unmet clinical needs by advancing treatment options and delivering safe, effective, and clinically valuable new therapies that improve the quality of life for patients with eye diseases worldwide.
Our mission is to be guided by clinical needs, leveraging existing drug compounds and innovative formulation strategies to accelerate the development of promising ophthalmic treatments. We actively collaborate with academia, industry, and research institutions to explore new therapeutic possibilities.
VISION
Our company is dedicated to the development of innovative ophthalmic drugs and has chosen “Caravel” as our brand name, inspired by the three-masted sailing ship. During the Age of Exploration, this vessel played a crucial role in pioneering and discovering new frontiers, symbolizing the courage to venture into the unknown.
We aspire to embody the same spirit, leading the ophthalmology field toward new horizons and bringing greater hope for treatment to patients. Additionally, “Caravel” resonates with the imagery of Taiwan’s Formosa, representing the essence of exploration and discovery on this beautiful land.
Through this name, we aim not only to create breakthroughs in ophthalmic drug development but also to pave the way for a brighter future in eye health for patients worldwide.